Opus Genetics (IRD)
NASDAQ:IRD
Holding IRD?
Track your performance easily

Opus Genetics (IRD) Financial Statements

989 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently ―. The company's EPS TTM is $-0.55; its P/E ratio is -2.45; Opus Genetics is scheduled to report earnings on November 8, 2024, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.11M$ 1.71M$ 1.69M$ 11.94M$ 3.67M
Gross Profit$ 1.11M$ 1.71M$ 1.69M$ 11.94M$ 3.67M
EBIT$ -7.76M$ -7.11M$ -4.80M$ 5.58M$ -4.96M
EBITDA$ -7.76M$ -7.11M$ -4.79M$ 5.58M-
Net Income Common Stockholders$ -7.76M$ -7.11M$ -4.79M$ 6.89M$ -4.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 41.41M$ 47.20M$ 50.52M$ 42.41M$ 40.02M
Total Assets$ 44.83M$ 51.84M$ 53.95M$ 54.19M$ 43.49M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -41.41M$ -47.20M$ -50.52M$ -42.41M$ -40.02M
Total Liabilities$ 4.20M$ 5.79M$ 4.04M$ 3.91M$ 5.76M
Stockholders Equity$ 40.64M$ 46.06M$ 49.91M$ 50.28M$ 37.70M
Cash Flow-
Free Cash Flow$ -7.29M$ -5.72M$ 4.55M$ -3.00M-
Operating Cash Flow$ -7.29M$ -5.72M$ 4.55M$ -3.00M-
Investing Cash Flow-----
Financing Cash Flow$ 1.54M$ 2.38M$ 3.60M$ 5.38M-
Currency in USD

Opus Genetics Earnings and Revenue History

Opus Genetics Debt to Assets

Opus Genetics Cash Flow

Opus Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis